Vinflunine Ditartrate
Vinflunine ditartrate is the ditartrate salt form of vinflunine, a third-generation fluorinated vinca alkaloid antineoplastic agent used for advanced urothelial carcinoma. The ditartrate salt provides aqueous solubility for intravenous administration. Its mechanism involves tubulin binding at the vinca domain with suppression of microtubule dynamic instability and inhibition of mitotic progression.
น้ำหนักโมเลกุล
1117.1000 g/mol
TPSA
364.00 Ų
กลไกการออกฤทธิ์
Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.
โครงสร้าง 2 มิติ
Cite this structure
Embed this structure
SMILES
CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
InChI
InChI=1S/C45H54F2N4O8.2C4H6O6/c1-8-42-14-11-16-51-17-15-43(36(42)51)30-19-31(34(56-5)20-33(30)49(4)37(43)45(55,40(54)58-7)38(42)59-25(2)52)44(39(53)57-6)21-26-18-27(41(3,46)47)23-50(22-26)24-29-28-12-9-10-13-32(28)48-35(29)44;2*5-1(3(7)8)2(6)4(9)10/h9-14,19-20,26-27,36-38,48,55H,8,15-18,21-24H2,1-7H3;2*1-2,5-6H,(H,7,8)(H,9,10)/t26-,27+,36-,37+,38+,42+,43+,44-,45-;;/m0../s1
Molecular Formula
C53H66F2N4O20
HBD / HBA
10 / 25
พันธะที่หมุนได้
16
อะตอมหนัก
79
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
คำถามที่พบบ่อย
Vinflunine ditartrate is the ditartrate salt form of vinflunine, a third-generation fluorinated vinca alkaloid antineoplastic agent used for advanced urothelial carcinoma. The ditartrate salt provides aqueous solubility for intravenous administration. Its mechanism involves tubulin binding at the vinca domain with suppression of microtubule dynamic instability and inhibition of mitotic progression.
Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.
Yes, Vinflunine Ditartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105629. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 16220212. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="vinflunine-ditartrate"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/vinflunine-ditartrate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/vinflunine-ditartrate/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/vinflunine-ditartrate/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="vinflunine-ditartrate"></drugfyi-drug>